TLR Agonist Nano Immune Therapy Clears Peritoneal and Systemic Ovarian Cancer.
Marwedel B, De May H, Anderson L, Medina LY, Kennedy E, Flores E, O'Rourke J, Olewine M, Lagutina I, Fitzpatrick L, Shultz F, Kusewitt DF, Bartee E, Adams S, Noureddine A, Serda RE.
Marwedel B, et al. Among authors: fitzpatrick l.
Adv Healthc Mater. 2024 Oct 31:e2402966. doi: 10.1002/adhm.202402966. Online ahead of print.
Adv Healthc Mater. 2024.
PMID: 39478634